• Birthplace - La Jolla, California
  • BS Bioengineering - University of California San Diego 2001
  • PhD Immunology - Baylor College of Medicine 2009
  • MD - Baylor College of Medicine 2010
  • Residency - John Hopkins University 2015
  • Clinical Focus - Head/Neck, GU Malignancies, Immunotherapy

Dr. Sharabi is a member of the Head & Neck and GU Cancer Disease Teams and oversees a Basic Science Laboratory within the Moores Cancer Center.

His research focus is on understanding the fundamental interactions between radiation and the immune system, and on identifying strategies to combine radiation with immunotherapy. He is the principal investigator of a randomized phase II clinical trial translating his preclinical laboratory work into patients as well as an early phase clinical trial evaluating the safety and efficacy of combining immunotherapy and SBRT in early stage lung cancer. He serves on the American Society for Radiation Oncology (ASTRO) Education Committee Immunotherapy Track and the National Cancer Institute (NCI) Clinical Trials Planning Committee.